ALTERATIONS IN THE KINETIC ACTIVITY OF AROMATIC-L-AMINO ACID DECARBOXYLASE AND PRELIMINARY 2-DE INVESTIGATION OF THE BRAINS IN A 6-OHDA INDUCED PARKINSON'S DISEASE RAT MODEL

Yıl 2003, Cilt: 16 Sayı: 3, 179 - 187, 03.12.2016

Aslıhan Günel Ayşe Ogan Filiz Onat Rezzan Aker

Öz

Objective: The aim of this study was to isolate and purify the aromatic-L-amino acid decarboxylase (AADC,EC 4.1.1.28) enzyme rats from Parkinson’s Disease (PD) induced and the healthy control group rat brains and compare the alterations in the kinetic activities of the isolated enzyme. The protein spots displaying on the 2-DE patterns of the diseased and the healthy control group crude rat brain homogenates were evaluated.
Medhods: In this study, the Parkinson’s Disease model was induced by injecting 6- hydroxydopamine into the brains of the rats. The PD model formation was successful in two rats out of three.
Results: The AADC decarboxylase was isolated and partially purified by DEAE-Sephacel ion exchange chromatography from the brains of PD induced and healthy control animals to compare the kinetic activity of the enzyme. The kinetic
activity of the enzyme was reduced 70% in the PD group compared to controls.
In order to determine and correlate the alterations with PD, and the distribution of the proteins displayed by the crude brain homogenates of the diseased and the healthy control group both were investigated. Polyacrylamide gel electrophoresis (PAGE) of the crude brain homogenates under the native and denaturizing conditions displayed matching bands for both of the groups, while two dimensional electrophoresis (2-DE) patterns of the crude brain homogenates of the diseased and the control group displayed considerable differences.
Conclusion: The results of this study confirm the power of 2-DE-PAGE technique of the proteome analysis. Currently only the proteome analysis enables the identification of disease correlated proteins.
Key Words: Proteome, Parkinson Disease, AADC, 2-DE

Kaynakça

• Cutillas B, Ambrosio S, Unzeta M, Tieuroprotective effect of the monoamine oxidase inhibitor PE 960in (Ti-(2-propyny!)-2- (5-benzyloxy-indolyl) methylamine] on rat nigral neurons after 6-hydroxydopamine- striatal lesion. ITeurosci Lett 2002:329; 165- 168.
• Christenson JQ, Dairman 14/, Udenfriend S. On the Identify of DOPA Decarboxylase and 5- Hydroxytryptophan Decarboxylase. Proc fiatl Acad Sci U.S.A. 1972;69:343-347.
• Yuwiler A, Geller E. Eiduson S. Studies on 5- Hyroxytryptophan Decarboxylase l.ln vitro Inhibition and Substrate Interaction. Arch Biochem Biophys 1959;80:162-1 73.
• Mailer A, Hyland K, Milstein S, Biaggioni I, Butter I.J. Aromatic-L-Amino Acid Decarboxylase deficiency: Clinical features, diagnosis and treatment of a second family. J Child rteurol 1997; 12:349-354.
• Qoldman SM, Tanner C. Etiology of Parkinson Disease In: Jankovic J, Tolosa E, eds Parkinson's Disease and Movement Disorders. 3 rd ed. Baltimore: Williams and Wilkins, 1998; 133-158.
• Bardo MT, Robinet P.M, Mattingly BA, Margulies JE. Effect of 6-Hydroxydopamine or repeated amphetamine treatment on mesencephalic mRTiA levels for AMPA glutamate receptor subunits in the rat. Tieurosci Lett 2001 ;302:133-136.
• Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates, 4™ ed. San Diego, California: Academic Press, 1998.
• Kirik D, Rosenblad C, Bjorklund A. Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-Hydroxydopamine in the rat. Exp TieuroI 1998;152:259-277.
• Preliminary proteome analysis of PD induced rat brains
• May FiC, Guilarte TR, Wagner FIM, Vogel S. Intrastriatal infusion of Lisuride-A potential treatment for Parkinson's Disease. Meurodegeneration 1994:3:305-313.
• Voitattorni CB, Dominici P. Moore PS. Modified purification of L-Aromatic Amino Acid Decarboxylase from pig kidney. Protein Expr Purif 1993;4:345-347.
• Lowry MO, Rosebrough MJ, Farr AL, Randall RJ, Protein Measurement with the Folin Phenol Reagent. J Biol Chem 1951 ; 193:265- 275.
• Johnstone AP. Thorpe R. Production and Assay of the Interleukins. J Immunol Methods 1985;83:1-27.
• Sherald A, Sparrow CJ. Wright RFT, A spectrophotometric assay for Drosophila Dopa Decarboxylase. Anal Biochem 1973; 56:300-305.
• Charteris A, John R. An investigation of the
• assay of Dopamine using
• Trinitrobenzenesuifonic Acid. Anal Biochem 1975;66:365-371.
• Voitattorni CB, Guartosio A, Turano C. Aromatic-L-Amino Acid Decarboxylase. Methods Enzymol 1987; 142:179-187.
• Davis BJ. Method and application to human serum proteins. Ann MY Acad Sci 1964;121:404-427.
• 7. Laemmli UK, Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Mature 1970; 227:680- 685.
• Jungblut P. Two-Dimensional Electrophoresis Protein Structure Analysis, Preparation, Characterization and Microsequencing. In: Kamp, RM, Choli-Papadopoulou T, Wittmann- Liebold B eds. Springer-Verlag, Inc., Berlin, Germany, 1997; 183-214.
• Eckerskorn C, Jungblut P, Mewes W, Klose J, Lottspeich F, Identification of mouse brain proteins after two dimensional electrophoresis and electroblotting by microsequence analysis and amino acid composition analysis. Electrophoresis 1988; 9:830-838.
• Ichinose fl, Kojima K, Togari A, et al. Simple
• purification of Aromatic-L-Amino Acid Decarboxylase from human
• pheochromocytoma. Anal Biochem 1985; 150:408-414.
• Mishigaki I, Ichinose FI, Tamai K, Magatsu T. Purification of Aromatic-L-Amino Acid Decarboxylase from bovine brain with a monoclonal antybody. Biochem. J 1988; 252:331-335.
• ¡9. Lineweaver fl, Burk D. The determination of enzyme dissosiation constants. J Amer Chem Soc 1934;56:658-666.